A study for a 31 year old woman who takes Vraylar, Spironolactone, Eskalith - from FDA reports


Summary

20 females aged 31 (±5) who take the same drugs are studied. This is a personalized study for a 31 year old female patient who has Female Pattern Baldness, Bipolar 1. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Sep, 10, 2017

20 females aged 31 (±5) who take Vraylar, Spironolactone, Eskalith are studied.


Number of reports submitted per year:

Vraylar, Spironolactone, Eskalith for a 31-year old woman.

Information of the patient in this study:

  • Age: 31
  • Gender: female
  • Conditions: Female Pattern Baldness, Bipolar 1
  • Drugs taken:
    • Vraylar (cariprazine hydrochloride)
    • Spironolactone (spironolactone)
    • Eskalith (lithium carbonate)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Numbness In Feet: 0 (0% of females aged 31 (±5) who take the drugs)
  • Cyanosis: 0 (0% of females aged 31 (±5) who take the drugs)
  • Lower Leg Pain: 0 (0% of females aged 31 (±5) who take the drugs)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common drug interactions over time

< 1 month:
  • trismus
  • papilloma viral infection
  • psychotic disorder
  • salivary hypersecretion
  • myositis
  • endometriosis
  • depression
  • obsessive rumination
1 - 6 months:
  • pain
  • bipolar disorder
  • gallstones
  • injury
6 - 12 months:
n/a
1 - 2 years:
n/a
2 - 5 years:
n/a
5 - 10 years:
n/a
10+ years:
n/a
not specified:
  • stress and anxiety
  • depression
  • weight decreased
  • colitis
  • rectal haemorrhage
  • gastroesophageal reflux disease
  • haematochezia
  • inflammatory bowel disease
  • pancreatitis
  • irritable bowel syndrome

Top conditions involved for these people *:

  • Migraine (9 people, 45.00%)
  • Pain (4 people, 20.00%)
  • Bipolar Disorder (3 people, 15.00%)
  • Asthma (3 people, 15.00%)
  • Multiple Allergies (2 people, 10.00%)

Top co-used drugs for these people *:

  • Prilosec (10 people, 50.00%)
  • Imitrex (9 people, 45.00%)
  • Sulfasalazine (8 people, 40.00%)
  • Accutane (8 people, 40.00%)
  • Neurontin (5 people, 25.00%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:

Related studies:

Can you answer these questions?

More questions for: Numbness in feet, Spironolactone, Bipolar 1, Lower leg pain, Vraylar, Cyanosis, Female pattern baldness, Eskalith

You may be interested in these reviews

More reviews for: Numbness in feet, Spironolactone, Bipolar 1, Lower leg pain, Vraylar, Cyanosis, Female pattern baldness, Eskalith